Description
Female Hormone CAS 71-58-9 Medroxyprogesterone Acetate in Stock Good Effect
Description
| Cas: | 71-58-9 | MF: | C24H34O4 |
|---|---|---|---|
| MW: | 386.52 | EINECS No.: | 200-757-9 |
| Boiling Point: | 432.7°C (rough Estimate) | Melting Point: | 206-207 °C(lit.) |
| Density: | 1.0346 (rough Estimate) | Storage: | Sealed In Dry,2-8°C |
| High Light: |
71-58-9 Medroxyprogesterone Acetate, Female Hormone Medroxyprogesterone Acetate |
||
Female Hormone CAS 71-58-9 Medroxyprogesterone Acetate in Stock Good Effect
Product introduction
| Product name | Medroxyprogesterone Acetate |
| CAS No. | 71-58-9 |
| MF | C24H34O4 |
| MW | 386.52 |
| EINECS No. | 200-757-9 |
| Density | 1.0346 (rough estimate) |
| Boiling Point | 432.7°C (rough estimate) |
| Melting Point | 206-207 °C(lit.) |
Description:
It is a progestogen, a synthetic variant of human progesterone, and a potent progesterone receptor agonist.
Uses:
Medrogesterone is mainly used for dysmenorrhea, functional amenorrhea, functional uterine bleeding, threatened or habitual abortion, endometriosis, advanced breast cancer, endometrial adenocarcinoma and kidney cancer. Large doses can be used as long-acting contraceptives. In addition, the effect is also reflected in the menstrual cramps because the endometrium loses the support of estrogen and progesterone and falls off, and it can continue to artificially supplement estrogen or progesterone, especially progesterone, so that the “helpless” endometrium continues to Get support and maintain a level of continued thickening, so that the lining of the uterus grows firmly on the uterine wall in preparation for the implantation of a fertilized egg, achieving the purpose of delaying menstruation.
Side Effects:
Similar to other progesterone drugs, breast pain, galactorrhea, amenorrhea, cervical erosion or changes in cervical secretion, and gynecomastia may occur.
Mental aspects: nervousness, insomnia, lethargy, fatigue, dizziness.
Skin and mucous membranes: Allergic reactions ranging from itching, measles, angioedema to generalized rashes and no defensive reactions have been reported, with a few reports of acne, baldness or hirsutism.
Gastrointestinal: Nausea and indigestion, especially at higher doses.
Body: Sometimes it can cause breast tenderness and abdominal distension.
May also produce similar adrenal cortisol response and hypercalcemia, and occasionally obstructive jaundice has been reported.
